HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-SEP-10 3OY3 TITLE CRYSTAL STRUCTURE OF ABL T315I MUTANT KINASE DOMAIN BOUND WITH A DFG- TITLE 2 OUT INHIBITOR AP24589 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 229-511; COMPND 5 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1, PROTO- COMPND 6 ONCOGENE C-ABL, P150; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: ABL1, ABL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN-INHIBITOR COMPLEX, PROTEIN KINASE TWO-DOMAIN FOLD, KEYWDS 2 PHOSPHOTRANSFERASE, ATP BINDING, PHOSPHORYLATION, TRANSFERASE- KEYWDS 3 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.ZHOU,L.COMMODORE,W.S.HUANG,Y.WANG,M.THOMAS,J.KEATS,Q.XU,V.RIVERA, AUTHOR 2 W.C.SHAKESPEARE,T.CLACKSON,D.C.DALGARNO,X.ZHU REVDAT 3 06-SEP-23 3OY3 1 REMARK SEQADV REVDAT 2 22-DEC-10 3OY3 1 JRNL REVDAT 1 15-DEC-10 3OY3 0 JRNL AUTH T.ZHOU,L.COMMODORE,W.S.HUANG,Y.WANG,M.THOMAS,J.KEATS,Q.XU, JRNL AUTH 2 V.M.RIVERA,W.C.SHAKESPEARE,T.CLACKSON,D.C.DALGARNO,X.ZHU JRNL TITL STRUCTURAL MECHANISM OF THE PAN-BCR-ABL INHIBITOR PONATINIB JRNL TITL 2 (AP24534): LESSONS FOR OVERCOMING KINASE INHIBITOR JRNL TITL 3 RESISTANCE. JRNL REF CHEM.BIOL.DRUG DES. V. 77 1 2011 JRNL REFN ISSN 1747-0277 JRNL PMID 21118377 JRNL DOI 10.1111/J.1747-0285.2010.01054.X REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.6 REMARK 3 NUMBER OF REFLECTIONS : 46310 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 2338 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4600 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 391 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.00500 REMARK 3 B22 (A**2) : -0.22400 REMARK 3 B33 (A**2) : 0.22900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.09100 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.513 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.325 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.249 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.178 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIGAND_589.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3OY3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-SEP-10. REMARK 100 THE DEPOSITION ID IS D_1000061716. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46310 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1IEP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% W/V POLYETHYLENE GLYCOL, 0.2 M REMARK 280 SODIUM ACETATE, 0.1 M TRS-HCL, PH 8.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.99400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 467 CG CD CE NZ REMARK 470 LYS B 467 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 229 152.24 178.76 REMARK 500 LYS A 245 -136.37 -120.92 REMARK 500 LYS A 274 96.66 85.84 REMARK 500 GLU A 275 -119.03 41.22 REMARK 500 ASP A 276 57.71 -146.31 REMARK 500 THR A 277 145.27 58.86 REMARK 500 MET A 278 -35.62 97.88 REMARK 500 ARG A 362 -9.23 78.88 REMARK 500 ASP A 363 53.90 -151.00 REMARK 500 ALA A 399 -156.40 -96.53 REMARK 500 ASP A 455 15.27 82.08 REMARK 500 LYS B 245 -143.30 -120.82 REMARK 500 LYS B 274 148.34 104.54 REMARK 500 ASP B 276 84.14 -45.46 REMARK 500 THR B 277 -157.75 -60.08 REMARK 500 MET B 278 -17.06 88.44 REMARK 500 ARG B 362 -16.85 81.95 REMARK 500 ASP B 363 50.56 -142.64 REMARK 500 ALA B 365 162.74 173.15 REMARK 500 HIS B 396 136.26 -171.51 REMARK 500 ASP B 455 20.93 81.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XY3 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XY3 B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3IK3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ABL T315I MUTANT BOUND WITH A DFG-OUT REMARK 900 INHIBITOR AP24534 REMARK 900 RELATED ID: 3OXZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ABL KINASE DOMAIN BOUND WITH A DFG-OUT REMARK 900 INHIBITOR AP24534 DBREF 3OY3 A 229 511 UNP P00520 ABL1_MOUSE 229 511 DBREF 3OY3 B 229 511 UNP P00520 ABL1_MOUSE 229 511 SEQADV 3OY3 GLY A 228 UNP P00520 EXPRESSION TAG SEQADV 3OY3 ILE A 315 UNP P00520 THR 315 ENGINEERED MUTATION SEQADV 3OY3 GLY B 228 UNP P00520 EXPRESSION TAG SEQADV 3OY3 ILE B 315 UNP P00520 THR 315 ENGINEERED MUTATION SEQRES 1 A 284 GLY SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG THR SEQRES 2 A 284 ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN TYR SEQRES 3 A 284 GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER LEU SEQRES 4 A 284 THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET GLU SEQRES 5 A 284 VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS GLU SEQRES 6 A 284 ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL CYS SEQRES 7 A 284 THR ARG GLU PRO PRO PHE TYR ILE ILE ILE GLU PHE MET SEQRES 8 A 284 THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS ASN SEQRES 9 A 284 ARG GLN GLU VAL SER ALA VAL VAL LEU LEU TYR MET ALA SEQRES 10 A 284 THR GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS LYS SEQRES 11 A 284 ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU SEQRES 12 A 284 VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE GLY SEQRES 13 A 284 LEU SER ARG LEU MET THR GLY ASP THR TYR THR ALA HIS SEQRES 14 A 284 ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU SEQRES 15 A 284 SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP VAL SEQRES 16 A 284 TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR TYR SEQRES 17 A 284 GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN VAL SEQRES 18 A 284 TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG PRO SEQRES 19 A 284 GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG ALA SEQRES 20 A 284 CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE ALA SEQRES 21 A 284 GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU SER SEQRES 22 A 284 SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY SEQRES 1 B 284 GLY SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG THR SEQRES 2 B 284 ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN TYR SEQRES 3 B 284 GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER LEU SEQRES 4 B 284 THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET GLU SEQRES 5 B 284 VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS GLU SEQRES 6 B 284 ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL CYS SEQRES 7 B 284 THR ARG GLU PRO PRO PHE TYR ILE ILE ILE GLU PHE MET SEQRES 8 B 284 THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS ASN SEQRES 9 B 284 ARG GLN GLU VAL SER ALA VAL VAL LEU LEU TYR MET ALA SEQRES 10 B 284 THR GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS LYS SEQRES 11 B 284 ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU SEQRES 12 B 284 VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE GLY SEQRES 13 B 284 LEU SER ARG LEU MET THR GLY ASP THR TYR THR ALA HIS SEQRES 14 B 284 ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU SEQRES 15 B 284 SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP VAL SEQRES 16 B 284 TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR TYR SEQRES 17 B 284 GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN VAL SEQRES 18 B 284 TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG PRO SEQRES 19 B 284 GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG ALA SEQRES 20 B 284 CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE ALA SEQRES 21 B 284 GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU SER SEQRES 22 B 284 SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY HET XY3 A 1 41 HET XY3 B 1 41 HETNAM XY3 5-[(5-{[4-{[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]METHYL}-3- HETNAM 2 XY3 (TRIFLUOROMETHYL)PHENYL]CARBAMOYL}-2-METHYLPHENYL) HETNAM 3 XY3 ETHYNYL]-1-METHYL-1H-IMIDAZOLE-2-CARBOXAMIDE FORMUL 3 XY3 2(C29 H31 F3 N6 O3) FORMUL 5 HOH *391(H2 O) HELIX 1 1 GLU A 238 THR A 240 5 3 HELIX 2 2 GLY A 249 GLN A 252 5 4 HELIX 3 3 LYS A 263 SER A 265 5 3 HELIX 4 4 GLU A 279 LYS A 291 1 13 HELIX 5 5 LEU A 323 CYS A 330 1 8 HELIX 6 6 SER A 336 LYS A 357 1 22 HELIX 7 7 ALA A 365 ARG A 367 5 3 HELIX 8 8 GLU A 373 HIS A 375 5 3 HELIX 9 9 GLY A 383 LEU A 387 5 5 HELIX 10 10 PRO A 402 THR A 406 5 5 HELIX 11 11 ALA A 407 ASN A 414 1 8 HELIX 12 12 SER A 417 THR A 434 1 18 HELIX 13 13 ASP A 444 SER A 446 5 3 HELIX 14 14 GLN A 447 LYS A 454 1 8 HELIX 15 15 PRO A 465 TRP A 476 1 12 HELIX 16 16 ASN A 479 ARG A 483 5 5 HELIX 17 17 SER A 485 GLU A 509 1 25 HELIX 18 18 GLU B 238 THR B 240 5 3 HELIX 19 19 GLY B 249 GLN B 252 5 4 HELIX 20 20 LYS B 263 SER B 265 5 3 HELIX 21 21 GLU B 279 LYS B 291 1 13 HELIX 22 22 LEU B 323 CYS B 330 1 8 HELIX 23 23 SER B 336 LYS B 357 1 22 HELIX 24 24 ALA B 365 ARG B 367 5 3 HELIX 25 25 GLU B 373 HIS B 375 5 3 HELIX 26 26 GLY B 383 LEU B 387 5 5 HELIX 27 27 PRO B 402 THR B 406 5 5 HELIX 28 28 ALA B 407 ASN B 414 1 8 HELIX 29 29 SER B 417 THR B 434 1 18 HELIX 30 30 ASP B 444 SER B 446 5 3 HELIX 31 31 GLN B 447 LYS B 454 1 8 HELIX 32 32 PRO B 465 TRP B 476 1 12 HELIX 33 33 ASN B 479 ARG B 483 5 5 HELIX 34 34 SER B 485 LEU B 510 1 26 SHEET 1 A 5 ILE A 242 LYS A 247 0 SHEET 2 A 5 VAL A 256 TRP A 261 -1 O GLU A 258 N HIS A 246 SHEET 3 A 5 LEU A 266 THR A 272 -1 O VAL A 268 N GLY A 259 SHEET 4 A 5 TYR A 312 GLU A 316 -1 O ILE A 315 N ALA A 269 SHEET 5 A 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 B 3 GLY A 321 ASN A 322 0 SHEET 2 B 3 CYS A 369 VAL A 371 -1 O VAL A 371 N GLY A 321 SHEET 3 B 3 VAL A 377 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 C 2 THR A 394 HIS A 396 0 SHEET 2 C 2 ALA A 399 PHE A 401 -1 O PHE A 401 N THR A 394 SHEET 1 D 5 ILE B 242 LYS B 247 0 SHEET 2 D 5 VAL B 256 TRP B 261 -1 O GLU B 258 N HIS B 246 SHEET 3 D 5 LEU B 266 THR B 272 -1 O VAL B 268 N GLY B 259 SHEET 4 D 5 TYR B 312 GLU B 316 -1 O ILE B 315 N ALA B 269 SHEET 5 D 5 GLY B 303 CYS B 305 -1 N GLY B 303 O ILE B 314 SHEET 1 E 3 GLY B 321 ASN B 322 0 SHEET 2 E 3 CYS B 369 VAL B 371 -1 O VAL B 371 N GLY B 321 SHEET 3 E 3 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 SHEET 1 F 2 THR B 394 HIS B 396 0 SHEET 2 F 2 ALA B 399 PHE B 401 -1 O ALA B 399 N HIS B 396 CISPEP 1 GLU A 275 ASP A 276 0 -14.39 CISPEP 2 PRO A 309 PRO A 310 0 -5.22 CISPEP 3 PRO B 309 PRO B 310 0 -6.62 SITE 1 AC1 23 HOH A 97 HOH A 197 LEU A 248 ALA A 269 SITE 2 AC1 23 LYS A 271 GLU A 286 MET A 290 ILE A 293 SITE 3 AC1 23 VAL A 299 ILE A 313 ILE A 315 PHE A 317 SITE 4 AC1 23 MET A 318 GLY A 321 ILE A 360 HIS A 361 SITE 5 AC1 23 ARG A 362 LEU A 370 VAL A 379 ALA A 380 SITE 6 AC1 23 ASP A 381 PHE A 382 HOH A 557 SITE 1 AC2 21 HOH B 121 HOH B 150 LEU B 248 ALA B 269 SITE 2 AC2 21 LYS B 271 GLU B 286 MET B 290 ILE B 293 SITE 3 AC2 21 LEU B 298 VAL B 299 ILE B 313 ILE B 315 SITE 4 AC2 21 PHE B 317 MET B 318 ILE B 360 HIS B 361 SITE 5 AC2 21 ARG B 362 VAL B 379 ALA B 380 ASP B 381 SITE 6 AC2 21 PHE B 382 CRYST1 66.471 59.988 89.439 90.00 97.97 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015044 0.000000 0.002106 0.00000 SCALE2 0.000000 0.016670 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011290 0.00000